The chemokine system in innate immunity

Cold Spring Harbor Perspectives in Biology

Volumn 7, Issue 5, 2015, Pages 1-20

  Sokol, Caroline L ^a   Luster, Andrew D ^a  

^a MASSACHUSETTS GENERAL HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CHEMOKINE;

HOMEOSTASIS; HUMAN; INFLAMMATION; INNATE IMMUNITY; PATHOPHYSIOLOGY; PHYSIOLOGY;

CHEMOKINES; HOMEOSTASIS; HUMANS; IMMUNITY, INNATE; INFLAMMATION;

EID: 84930471281     PISSN: None     EISSN: 19430264     Source Type: Journal    
DOI: 10.1101/cshperspect.a016303     Document Type: Article

References (105)

1. Auffray C, Fogg D, Garfa M, Elain G, Join-Lambert O, Kayal S, Sarnacki S, Cumano A, Lauvau G, Geissmann F. 2007. Monitoring of blood vessels and tissues by a population of monocytes with patrolling behavior. Science 317: 666–670.
2. Bachelerie FB-BA, Burkhardt AM, Combadiere C, Farber JM, Graham GJ, Horuk R, Sparre-Ulrich AH, Locati M, Luster AD, Mantovani A, et al. 2013. International Union of Basic and Clinical Pharmacology. LXXXIX. Update on the extended family of chemokine receptors and introducing a new nomenclature for atypical chemokine receptors. Pharmacol Rev 11: 1–79.
3. Bajenoff M, Breart B, Huang AY, Qi H, Cazareth J, Braud VM, Germain RN, Glaichenhaus N. 2006. Natural killer cell behavior in lymph nodes revealed by static and realtime imaging. J Exp Med 203: 619–631.
4. Bennouna S, Bliss SK, Curiel TJ, Denkers EY. 2003. Crosstalk in the innate immune system: Neutrophils instruct recruitment and activation of dendritic cells during mi-crobial infection. J Immunol 171: 6052–6058.
5. Bernhagen J, Krohn R, Lue H, Gregory JL, Zernecke A, Koenen RR, Dewor M, Georgiev I, Schober A, Leng L, et al. 2007. MIF is a noncognate ligand of CXC chemo-kine receptors in inflammatory and atherogenic cell recruitment. Nat Med 13: 587–596.
6. Bogunovic M, Ginhoux F, Wagers A, Loubeau M, Isola LM, Lubrano L, Najfeld V, Phelps RG, Grosskreutz C, Sci-gliano E, et al. 2006. Identification of a radio-resistant and cycling dermal dendritic cell population in mice and men. J Exp Med 203: 2627–2638.
7. Braun A, Worbs T, Moschovakis GL, Halle S, Hoffmann K, Bolter J, Munk A, Forster R. 2011. Afferent lymph-derived T cells and DCs use different chemokine receptor CCR7-dependent routes for entry into the lymph node and intranodal migration. Nat Immunol 12: 879–887.
8. Bromley SK, Mempel TR, Luster AD. 2008. Orchestrating the orchestrators: Chemokines in control of T cell traffic. Nat Immunol 9: 970–980.
9. Broxmeyer HE, Orschell CM, Clapp DW, Hangoc G, Cooper S, Plett PA, Liles WC, Li X, Graham-Evans B, Campbell TB, et al. 2005. Rapid mobilizationof murine and human hematopoietic stem and progenitor cells with AMD3100, a CXCR4 antagonist. J Exp Med 201: 1307–1318.
10. Castellino F, Huang AY, Altan-Bonnet G, Stoll S, Scheinecker C, Germain RN. 2006. Chemokines enhance immunity by guiding naive CD8þ T cells to sites of CD4þ T cell-dendritic cell interaction. Nature 440: 890–895.
11. Chen M, Lam BK, Kanaoka Y, Nigrovic PA, Audoly LP, Austen KF, Lee DM. 2006. Neutrophil-derived leukotriene B4 is required for inflammatory arthritis. J Exp Med 203: 837–842.
12. Chou RC, Kim ND, Sadik CD, Seung E, Lan Y, Byrne MH, Haribabu B, Iwakura Y, Luster AD. 2010. Lipid-cytokine-chemokine cascade drives neutrophil recruitment in a murine model of inflammatory arthritis. Immunity 33: 266–278.
13. Constantinides MG, McDonald BD, Verhoef PA, Bendelac A. 2014.Acommitted precursorto innatelymphoid cells. Nature 508: 397–401.
14. Cook DN, Prosser DM, Forster R, Zhang J, Kuklin NA, Abbondanzo SJ, Niu XD, Chen SC, Manfra DJ, Wiekow-ski MT, et al. 2000. CCR6 mediates dendritic cell locali-zation, lymphocyte homeostasis, and immune responses in mucosal tissue. Immunity 12: 495–503.
15. Cruz-Orengo L, Holman DW, Dorsey D, Zhou L, Zhang P, Wright M, McCandless EE, Patel JR, Luker GD, Littman DR, et al. 2011. CXCR7 influences leukocyte entry into the CNS parenchyma by controlling abluminal CXCL12 abundance during autoimmunity. J Exp Med 208: 327–339.
16. Cuvelier SL, Patel KD. 2001. Shear-dependent eosinophil transmigration on interleukin 4-stimulated endothelial cells: A role for endothelium-associated eotaxin-3. J Exp Med 194: 1699–1709.
17. Czeloth N, Schippers A, Wagner N, Muller W, Kuster B, Bernhardt G, Forster R. 2007. Sphingosine-1 phosphate signaling regulates positioning of dendritic cells within the spleen. J Immunol 179: 5855–5863.
18. De Filippo K, Dudeck A, Hasenberg M, Nye E, van Rooijen N, Hartmann K, Gunzer M, Roers A, Hogg N. 2013. Mast cell and macrophage chemokines CXCL1/CXCL2 control the early stage of neutrophil recruitment during tissue inflammation. Blood 121: 4930–4937.
19. Devi S, Wang Y, Chew WK, Lima R, A-González N, Mattar CN, Chong SZ, Schlitzer A, Bakocevic N, Chew S, et al. 2013. Neutrophil mobilization via plerixafor-mediated CXCR4 inhibition arises from lung demargination and blockade of neutrophil homing to the bone marrow. J Exp Med 210: 2321–2336.
20. DeVries ME, Kelvin AA, Xu L, Ran L, Robinson J, Kelvin DJ. 2006. Defining the origins and evolution of the chemo- kine/chemokine receptor system. J Immunol 176: 401–415.
21. Forster R, Schubel A, Breitfeld D, Kremmer E, Renner-Mul-ler I, Wolf E, Lipp M. 1999. CCR7 coordinates the primary immune responsebyestablishing functional micro-environments in secondary lymphoid organs. Cell 99: 23–33.
22. Foussat A, Coulomb-L’Hermine A, Gosling J, Krzysiek R, Durand-Gasselin I, Schall T, Balian A, Richard Y, Gala-naud P, Emilie D.2000. Fractalkine receptor expression by T lymphocyte subpopulations and in vivo production of fractalkine in human. Eur J Immunol 30: 87–97.
23. Gatto D, Wood K, Caminschi I, Murphy-Durland D, Scho-field P, Christ D, Karupiah G, Brink R. 2013. The chemo-tactic receptor EBI2 regulates the homeostasis, localization and immunological function of splenic dendritic cells. Nat Immunol 14: 446–453.
24. Geissmann F, Jung S, Littman DR. 2003. Blood monocytes consist of two principal subsets with distinct migratory properties. Immunity 19: 71–82.
25. Gerszten RE, Garcia-Zepeda EA, Lim YC, Yoshida M, Ding HA, Gimbrone MA Jr, Luster AD, Luscinskas FW, Rose-nzweig A. 1999. MCP-1 and IL-8 trigger firm adhesion of monocytes to vascular endothelium under flow conditions. Nature 398: 718–723.
26. Gonzalo JA, Qiu Y, Lora JM, Al-Garawi A, Villeval JL, Boyce JA, Martinez A C, Marquez G, Goya I, Hamid Q, et al. 2007. Coordinated involvement of mast cells and T cells in allergic mucosal inflammation: Critical role of the CC chemokine ligand 1:CCR8 axis. J Immunol 179: 1740–1750.
27. Groom JR, Luster AD. 2011. CXCR3 ligands: Redundant, collaborative and antagonistic functions. Immunol Cell Biol 89: 207–215.
28. Groom JR, Richmond J, Murooka TT, Sorensen EW, Sung JH, Bankert K, von Andrian UH, Moon JJ, Mempel TR, Luster AD. 2012. CXCR3 chemokine receptor-ligand interactions in the lymph node optimize CD4þ T helper 1 cell differentiation. Immunity 37: 1091–1103.
29. Gulino AV, Moratto D, Sozzani S, Cavadini P, Otero K, Tas-sone L, Imberti L, Pirovano S, Notarangelo LD, Soresina R, et al. 2004. Altered leukocyte response to CXCL12 in patients with warts hypogammaglobulinemia, infections, myelokathexis (WHIM) syndrome. Blood 104: 444–452.
30. Halim TY, Steer CA, Matha L, Gold MJ, Martinez-Gonzalez I, McNagny KM, McKenzie AN, Takei F. 2014. Group 2 innate lymphoid cells are critical for the initiation of adaptive T helper 2 cell-mediated allergic lung inflammation. Immunity 40: 425–435.
31. Halova I, Draberova L, Draber P. 2012. Mast cell chemotax-is—Chemoattractants and signaling pathways. Front Immunol 3: 119.
32. Hancock WW, Gao W, Csizmadia V, Faia KL, Shemmeri N, Luster AD. 2001. Donor-derived IP-10 initiates development of acute allograft rejection. J Exp Med 193: 975–980.
33. Hao J, Liu R, Piao W, Zhou Q, Vollmer TL, Campagnolo DI, Xiang R, La Cava A, Van Kaer L, Shi FD. 2010. Central nervous system (CNS)-resident natural killer cells suppress Th17 responses and CNS autoimmune pathology. J Exp Med 207: 1907–1921.
34. Hernandez PA, Gorlin RJ, Lukens JN, Taniuchi S, Bohinjec J, Francois F, Klotman ME, Diaz GA. 2003. Mutations in the chemokine receptor gene CXCR4 are associated with WHIM syndrome, a combined immunodeficiency disease. Nat Genet 34: 70–74.
35. Hickman HD, Li L, Reynoso GV, Rubin EJ, Skon CN, Mays JW, Gibbs J, Schwartz O, Bennink JR, Yewdell JW. 2011. Chemokines control naive CD8þ T cell selection of optimal lymph node antigen presenting cells. J Exp Med 208: 2511–2524.
36. Hillyer P, Male D. 2005. Expression of chemokines on the surface of different human endothelia. Immunol Cell Biol 83: 375–382.
37. Hokeness KL, Kuziel WA, Biron CA, Salazar-Mather TP. 2005. Monocyte chemoattractant protein-1 and CCR2 interactions are required for IFN-a/b-induced inflammatory responses and antiviral defense in liver. J Immunol 174: 1549–1556.
38. Humbles AA, Lu B, Friend DS, Okinaga S, Lora J, Al-Garawi A, Martin TR, Gerard NP, Gerard C. 2002. The murine CCR3 receptor regulates both the role of eosinophils and mast cells in allergen-induced airway inflammation and hyperresponsiveness. Proc Natl Acad Sci 99: 1479–1484.
39. Kagnoff MF, Eckmann L. 1997. Epithelial cells as sensors for microbial infection. J Clin Invest 100: 6–10.
40. Kastenmuller W, Torabi-Parizi P, Subramanian N, Lammer-mann T, Germain RN. 2012. A spatially organized mul-ticellular innate immune response in lymph nodes limits systemic pathogen spread. Cell 150: 1235–1248.
41. Kastenmuller W, Brandes M, Wang Z, Herz J, Egen JG, Germain RN. 2013. Peripheral prepositioning and local CXCL9 chemokine-mediated guidance orchestrate rapidmemory CD8þ T cell responses in the lymph node. Immunity 38: 502–513.
42. Khan IA, Thomas SY, Moretto MM, Lee FS, Islam SA, Combe C, Schwartzman JD, Luster AD. 2006. CCR5 is essential for NK cell trafficking and host survival following Toxoplasma gondii infection. PLoS Pathog 2: e49.
43. Kim ND, Chou RC, Seung E, Tager AM, Luster AD. 2006. A unique requirement for the leukotriene B4 receptor BLT1 for neutrophil recruitment in inflammatory arthritis. J Exp Med 203: 829–835.
44. Kurth I, Willimann K, Schaerli P, Hunziker T, Clark-Lewis I, Moser B. 2001. Monocyte selectivity and tissue localization suggests a role for breast and kidney-expressed che-mokine (BRAK) in macrophage development. J Exp Med 194: 855–861.
45. Kuziel WA, Morgan SJ, Dawson TC, Griffin S, Smithies O, Ley K, Maeda N. 1997. Severe reduction in leukocyte adhesion and monocyte extravasation in mice deficient in CC chemokine receptor 2. Proc Natl Acad Sci 94: 12053–12058.
46. Lammermann T, Afonso PV, Angermann BR, Wang JM, Kastenmuller W, Parent CA, Germain RN. 2013. Neutro-phil swarms require LTB4 and integrins at sites of cell death in vivo. Nature 498: 371–375.
47. Landsman L, Bar-On L, Zernecke A, Kim KW, Krauthgamer R, Shagdarsuren E, Lira SA, Weissman IL, Weber C, Jung S. 2009. CX3CR1 is required for monocyte homeostasis and atherogenesis by promoting cell survival. Blood 113: 963–972.
48. Le Borgne M, Etchart N, Goubier A, Lira SA, Sirard JC, van Rooijen N, Caux C, Ait-Yahia S, Vicari A, Kaiserlian D, et al. 2006. Dendritic cells rapidly recruited into epithelial tissues via CCR6/CCL20 are responsible for CD8þ T cell crosspriming in vivo. Immunity 24: 191–201.
49. Leon B, Ballesteros-Tato A, Browning JL, Dunn R, Randall TD, Lund FE. 2012. Regulation of TH2 development by CXCR5þ dendritic cells and lymphotoxin-expressing B cells. Nat Immunol 13: 681–690.
50. Maghazachi AA. 2010. Role of chemokines in the biology of natural killer cells. Curr Top Microbiol Immunol 341: 37–58.
51. Marone G, Triggiani M, de Paulis A. 2005. Mast cells and basophils: Friends as well as foes in bronchial asthma? Trends Immunol 26: 25–31.
52. Marshall JS. 2004. Mast-cell responsestopathogens. Nat Rev Immunol 4: 787–799.
53. Martin C, Burdon PC, Bridger G, Gutierrez-Ramos JC, Williams TJ, Rankin SM. 2003. Chemokines acting via CXCR2 and CXCR4 control the release of neutrophils from the bone marrow and their return following senescence. Immunity 19: 583–593.
54. Martin-Fontecha A, Thomsen LL, Brett S, Gerard C, Lipp M, Lanzavecchia A, Sallusto F. 2004. Induced recruitment of NK cellsto lymph nodes provides IFN-g for TH1 priming. Nat Immunol 5: 1260–1265.
55. Mattes J, Yang M, Mahalingam S, Kuehr J, Webb DC, Simson L, Hogan SP, Koskinen A, McKenzie AN, Dent LA, et al. 2002. Intrinsic defect in T cell production of interleukin (IL)-13 in the absence of both IL-5 and eotaxin precludes the development of eosinophilia and airways hyperreac-tivity in experimental asthma. J Exp Med 195: 1433– 1444.
56. McDonald B, Pittman K, Menezes GB, Hirota SA, Slaba I, Waterhouse CC, Beck PL, Muruve DA, Kubes P. 2010. Intravascular danger signals guide neutrophils to sites of sterile inflammation. Science 330: 362–366.
57. Menzies-Gow A, Robinson DS. 2001. Eosinophil chemo-kines and chemokine receptors: Their role in eosinophil accumulation and activation in asthma and potential as therapeutic targets. J Asthma 38: 605–613.
58. Mercier FE, Ragu C, Scadden DT. 2012. The bone marrow at the crossroads of blood and immunity. Nat Rev Immunol 12: 49–60.
59. Meuter S, Schaerli P, Roos RS, Brandau O, Bosl MR, von Andrian UH, Moser B. 2007. Murine CXCL14 is dispensable for dendritic cell function and localization within peripheral tissues. Mol Cell Biol 27: 983–992.
60. Mishra A, Hogan SP, Lee JJ, Foster PS, Rothenberg ME. 1999. Fundamental signals that regulate eosinophil homing to the gastrointestinal tract. J Clin Invest 103: 1719–1727.
61. Moatti D, Faure S, Fumeron F, Amara Mel W, Seknadji P, McDermott DH, Debre P, Aumont MC, Murphy PM, de Prost D, et al. 2001. Polymorphism in the fractalkine receptor CX3CR1 as a genetic risk factor for coronary artery disease. Blood 97: 1925–1928.
62. Nilsson G, Johnell M, Hammer CH, Tiffany HL, Nilsson K, Metcalfe DD, Siegbahn A, Murphy PM. 1996. C3a and C5a are chemotaxins for human mast cells and act through distinct receptors via a pertussis toxin-sensitive signal transduction pathway. J Immunol 157: 1693–1698.
63. Nomiyama H, Osada N, Yoshie O. 2010. The evolution of mammalian chemokine genes. Cytokine Growth Factor Rev 21: 253–262.
64. Ochi H, Hirani WM, Yuan Q, Friend DS, Austen KF, Boyce JA. 1999. T helper cell type 2 cytokine-mediated comito-genic responses and CCR3 expression during differentiation of human mast cells in vitro. J Exp Med 190: 267–280.
65. Oghumu S, Dong R, Varikuti S, Shawler T, Kampfrath T, Terrazas CA, Lezama-Davila C, Ahmer BM, Whitacre CC, Rajagopalan S, et al. 2013. Distinct populations of innate CD8þ T cells revealed ina CXCR3 reporter mouse. J Immunol 190: 2229–2240.
66. Ohl L, Mohaupt M, Czeloth N, Hintzen G, Kiafard Z, Zwirner J, Blankenstein T, Henning G, Forster R. 2004. CCR7 governs skin dendritic cell migration under inflammatory and steady-state conditions. Immunity 21: 279–288.
67. Palframan RT, Collins PD, Williams TJ, Rankin SM. 1998. Eotaxin induces a rapid release of eosinophils and their progenitors from the bone marrow. Blood 91: 2240–2248.
68. Palframan RT, Jung S, Cheng G, Weninger W, Luo Y, Dorf M, Littman DR, Rollins BJ, Zweerink H, Rot A, et al. 2001. Inflammatory chemokine transport and presentation in HEV: A remote control mechanism for monocyte recruitment to lymph nodes in inflamed tissues. J Exp Med 194: 1361–1373.
69. Pflicke H, Sixt M. 2009. Preformed portals facilitate dendritic cell entry into afferent lymphatic vessels. J Exp Med 206: 2925–2935.
70. Piqueras B, Connolly J, Freitas H, Palucka AK, Banchereau J. 2006. Upon viral exposure, myeloid and plasmacytoid dendritic cells produce 3 waves of distinct chemokines to recruit immune effectors. Blood 107: 2613–2618.
71. Pope SM, Zimmermann N, Stringer KF, Karow ML, Roth-enberg ME. 2005. The eotaxin chemokines and CCR3 are fundamental regulators of allergen-induced pulmonary eosinophilia. J Immunol 175: 5341–5350.
72. Possot C, Schmutz S, Chea S, Boucontet L, Louise A, Cu-mano A, Golub R. 2011. Notch signaling is necessary for adult, but not fetal, development of RORgtþ innate lym-phoid cells. Nat Immunol 12: 949–958.
73. Proebstl D, Voisin MB, Woodfin A, Whiteford J, D’Acquisto F, Jones GE, Rowe D, Nourshargh S. 2012. Pericytes support neutrophil subendothelial cell crawling and breaching of venular walls in vivo. J Exp Med 209: 1219–1234.
74. Proudfoot AE, Handel TM, Johnson Z, Lau EK, LiWang P, Clark-Lewis I, Borlat F, Wells TN, Kosco-Vilbois MH. 2003. Glycosaminoglycan binding and oligomerization are essential for the in vivo activityof certain chemokines. Proc Natl Acad Sci 100: 1885–1890.
75. Pruenster M, Mudde L, Bombosi P, Dimitrova S, Zsak M, Middleton J, Richmond A, Graham GJ, Segerer S, Nibbs RJ, et al. 2009. The Duffy antigen receptor for chemo-kines transports chemokines and supports their promi-gratory activity. Nat Immunol 10: 101–108.
76. Randolph GJ, Ochando J, Partida-Sanchez S. 2008. Migration of dendritic cell subsets and their precursors. Annu Rev Immunol 26: 293–316.
77. Roediger B, Kyle R, Yip KH, Sumaria N, Guy TV, Kim BS, Mitchell AJ, Tay SS, Jain R, Forbes-Blom E, et al. 2013. Cutaneous immunosurveillance and regulation of inflammation by group 2 innate lymphoid cells. Nat Immunol 14: 564–573.
78. Sadik CD, Kim ND, Iwakura Y, Luster AD. 2012. Neutrophils orchestrate their own recruitment in murine arthritis through C5aR and FcgR signaling. Proc Natl Acad Sci 109: E3177–E3185.
79. Sallusto F, Schaerli P, Loetscher P, Schaniel C, Lenig D, Mackay CR, Qin S, Lanzavecchia A. 1998. Rapid and coordinated switch in chemokine receptor expression during dendritic cell maturation. Eur J Immunol 28: 2760–2769.
80. Sawa S, Cherrier M, Lochner M, Satoh-Takayama N, Fehling HJ, Langa F, Di Santo JP, Eberl G. 2010. Lineage relationship analysis of RORgtþ innate lymphoid cells. Science 330: 665–669.
81. Schaerli P, Willimann K, Ebert LM, Walz A, Moser B. 2005. Cutaneous CXCL14 targets blood precursors to epidermal niches for Langerhans cell differentiation. Immunity 23: 331–342.
82. Semmling V, Lukacs-Kornek V, Thaiss CA, Quast T, Hoch-heiser K, Panzer U, Rossjohn J, Perlmutter P, Cao J, Godfrey DI, et al. 2010. Alternative cross-priming through CCL17-CCR4-mediated attraction of CTLs toward NKT cell-licensed DCs. Nat Immunol 11: 313–320.
83. Serbina NV, Pamer EG. 2006. Monocyte emigration from bone marrow during bacterial infection requires signals mediated by chemokine receptor CCR2. Nat Immunol 7: 311–317.
84. Shi C, Pamer EG. 2011. Monocyte recruitment during infection and inflammation. Nat Rev Immunol 11: 762–774.
85. Shi C, Jia T, Mendez-Ferrer S, Hohl TM, Serbina NV, Li-puma L, Leiner I, Li MO, Frenette PS, Pamer EG. 2011. Bone marrow mesenchymal stem and progenitor cells induce monocyte emigration in response to circulating toll-like receptor ligands. Immunity 34: 590–601.
86. Sojka DK, Plougastel-Douglas B, Yang L, Pak-Wittel MA, Artyomov MN, Ivanova Y, Zhong C, Chase JM, Rothman PB, Yu J, et al. 2014. Tissue-resident natural killer (NK) cells are cell lineages distinct from thymic and conventional splenic NK cells. eLife 3: e01659.
87. Stark K, Eckart A, Haidari S, Tirniceriu A, Lorenz M, von Bruhl ML, Gartner F, Khandoga AG, Legate KR, Pless R, et al. 2013. Capillary and arteriolar pericytes attract innate leukocytes exiting through venules and “instruct” them with pattern-recognition and motility programs. Nat Immunol 14: 41–51.
88. Struyf S, Proost P, Schols D, De Clercq E, Opdenakker G, Lenaerts JP, Detheux M, Parmentier M, De Meester I, Scharpe S, et al. 1999. CD26/dipeptidyl-peptidase IV down-regulates the eosinophil chemotactic potency, but not the anti-HIV activity of human eotaxin by affecting its interaction with CC chemokine receptor 3. J Immunol 162: 4903–4909.
89. Suratt BT, Petty JM, Young SK, Malcolm KC, Lieber JG, Nick JA, Gonzalo JA, Henson PM, Worthen GS. 2004. Role of the CXCR4/SDF-1 chemokine axis in circulating neutro-phil homeostasis. Blood 104: 565–571.
90. Tal O, Lim HY, Gurevich I, Milo I, Shipony Z, Ng LG, Angeli V, Shakhar G. 2011. DC mobilization from the skin requires docking to immobilized CCL21 on lymphatic en-dothelium and intralymphatic crawling. J Exp Med 208: 2141–2153.
91. Thomas SY, Scanlon ST, Griewank KG, Constantinides MG, Savage AK, Barr KA, Meng F, Luster AD, Bendelac A. 2011. PLZF induces an intravascular surveillance program mediated by long-lived LFA-1-ICAM-1 interactions. J Exp Med 208: 1179–1188.
92. Uguccioni M, Mackay CR, Ochensberger B, Loetscher P, Rhis S, LaRosa GJ, Rao P, Ponath PD, Baggiolini M, Da-hinden CA. 1997. High expression of the chemokine receptor CCR3 in human blood basophils. Role in activation by eotaxin, MCP-4, and other chemokines. J Clin Invest 100: 1137–1143.
93. Varona R, Villares R, Carramolino L, Goya I, Zaballos A, Gutierrez J, Torres M, Martinez AC, Marquez G. 2001. CCR6-deficient mice have impaired leukocyte homeosta-sis and altered contact hypersensitivity and delayed-type hypersensitivity responses. J Clin Invest 107: R37–R45.
94. Wald O, Weiss ID, Wald H, Shoham H, Bar-Shavit Y, Beider K, Galun E, Weiss L, Flaishon L, Shachar I, et al. 2006. IFN-g acts on T cells to induce NK cell mobilization and accumulation in target organs. J Immunol 176: 4716–4729.
95. Walker JA, Barlow JL, McKenzie AN. 2013. Innate lymphoid cells—How did we miss them? Nat Rev Immunol 13: 75–87.
96. Wang Y, Cui L, Gonsiorek W, Min SH, Anilkumar G, Rose-nblum S, Kozlowski J, Lundell D, Fine JS, Grant EP. 2009. CCR2 and CXCR4 regulate peripheral blood monocyte pharmacodynamics and link to efficacy in experimental autoimmune encephalomyelitis. J Inflamm (Lond) 6: 32.
97. Weber C, Weber KS, Klier C, Gu S, Wank R, Horuk R, Nelson PJ. 2001. Specialized roles of the chemokine receptors CCR1 and CCR5 in the recruitment of monocytes and TH1-like/CD45ROþ T cells. Blood 97: 1144–1146.
98. Weber M, Hauschild R, Schwarz J, Moussion C, de Vries I, Legler DF, Luther SA, Bollenbach T, Sixt M. 2013. Interstitial dendritic cell guidance by haptotactic chemokine gradients. Science 339: 328–332.
99. Wehr A, Baeck C, Heymann F, Niemietz PM, Hammerich L, Martin C, Zimmermann HW, Pack O, Gassler N, Hittatiya K, et al. 2013. Chemokine receptor CXCR6-de-pendent hepatic NK T cell accumulation promotes inflammation and liver fibrosis. J Immunol 190: 5226–5236.
100. Wong CK, Hu S, Cheung PF, Lam CW. 2010.Thymicstromal lymphopoietin induces chemotactic and prosurvival effects in eosinophils: Implications in allergic inflammation. Am J Respir Cell Mol Biol 43: 305–315.
101. Worbs T, Bode U, Yan S, Hoffmann MW, Hintzen G, Bern-hardt G, Forster R, Pabst O. 2006. Oral tolerance originates in the intestinal immune system and relies on antigen carriage by dendritic cells. J Exp Med 203: 519–527.
102. Yan S, Gessner R, Dietel C, Schmiedek U, Fan H. 2012. Enhanced ovalbumin-induced airway inflammation in CD262/2 mice. Eur J Immunol 42: 533–540.
103. Yuan Q, Campanella GS, Colvin RA, Hamilos DL, Jones KJ, Mathew A, Means TK, Luster AD. 2006. Membrane-bound eotaxin-3 mediates eosinophil transepithelial migration in IL-4-stimulated epithelial cells. Eur J Immunol 36: 2700–2714.
104. Zhang Q, Raoof M, Chen Y, Sumi Y, Sursal T, Junger W, Brohi K, Itagaki K, Hauser CJ. 2010. Circulating mito-chondrial DAMPs cause inflammatory responses to injury. Nature 464: 104–107.
105. Zlotnik A, Yoshie O, Nomiyama H. 2006. The chemokine and chemokine receptor superfamilies and their molecular evolution. Genome Biol 7: 243.